Table 4. Incidence of AEs.

Treatment-related AEs	Any grade	Grade ≥3
Anemia	12 (23.1)	0 (0.0)
White blood cell count decreased	2 (3.8)	0 (0.0)
Neutrophil count decreased	2 (3.8)	2 (3.8)
Platelet count decreased	5 (9.6)	1 (1.9)
Pneumonitis	5 (9.6)	0 (0.0)
Nausea and/or vomiting	0 (0.0)	0 (0.0)
Hand-foot syndrome	1 (1.9)	0 (0.0)
Dizziness	2 (3.8)	0 (0.0)
Abdominal distension	1 (1.9)	0 (0.0)
Fatigue	4 (7.7)	0 (0.0)
Hypertension	0 (0.0)	0 (0.0)
Hypothyroidism	2 (3.8)	0 (0.0)
Elevated creatinine	5 (9.6)	0 (0.0)
Elevated AST/ALT	4 (7.7)	0 (0.0)
Elevated serum amylase	1 (1.9)	0 (0.0)

Data are presented as n (%). AE, adverse event; ALT, alanine aminotransferase; AST, aspartate transaminase.